Research and Markets (http://www.researchandmarkets.com/research/lrslm8/thyroid_cancer) has announced the addition of the "Thyroid Cancer Forecast in 17 Major Markets 2015-2025" report to their offering.

Thyroid Cancer is a cancer originating from follicular or parafollicular thyroid cells. It is a relatively rare cancer, but the most common of the endocrine system. The main clinical split is between differentiated and undifferentiated tumour types, with the majority being well-differentiated.

This report provides the current incidence population for Thyroid Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, Canada, Australia, India, Mexico, Turkey, South Africa, Saudi Arabia, Argentina and Russia) split by gender and 5-year age cohort. Along with the current incidence, the report provides an overview of the stages, locations and histopathology of Thyroid Cancer tumours. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Several of the main symptoms of Thyroid Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Thyroid Cancer include:

- Familial Adenomatous Polyposis

- Acromegaly

- Diabetes

- Multiple endocrine neoplasia syndromes

- Sipple syndrome

Reason to buy

- Able to quantify patient populations in global Thyroid Cancer's market to target the development of future products, pricing strategies and launch plans.

- Gain further insight into the incidence of the subdivided types of Thyroid Cancer and identify patient segments with high potential.

- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

- Provide a level of understanding on the impact from specific co-morbid conditions on Thyroid Cancer's incident population.

- Examination of the incidence of the different causative gene mutations for Thyroid Cancer.

- Identify sub-populations within Thyroid Cancer which require treatment.

- Gain an understanding of the specific markets that have the largest number of Thyroid Cancer patients

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key Co-morbid Conditions/ Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Thyroid Cancer Incidence

10. Types of Thyroid Cancer

11. Thyroid Cancer by Stage

12. Abbreviations used in the Report

13. Patient-Based Offering

14. Online Pricing Data and Platforms

15. References

16. Appendix

For more information visit http://www.researchandmarkets.com/research/lrslm8/thyroid_cancer